189 related articles for article (PubMed ID: 33893224)
1. Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease.
Shen CR; Jia XY; Luo W; Olaru F; Cui Z; Zhao MH; Borza DB
J Am Soc Nephrol; 2021 Aug; 32(8):1887-1897. PubMed ID: 33893224
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers.
Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB
J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673
[TBL] [Abstract][Full Text] [Related]
3. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
5. Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease.
Gray PE; McCarthy H; Siggs OM; Saleem MA; O' Brien T; Frith K; Ziegler JB; Kitching AR; Fogo AB; Hudson BG; Pedchenko V
Front Immunol; 2019; 10():2659. PubMed ID: 31798588
[No Abstract] [Full Text] [Related]
6. Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.
Jia XY; Cui Z; Yang R; Hu SY; Zhao MH
Clin J Am Soc Nephrol; 2012 Jun; 7(6):926-33. PubMed ID: 22461538
[TBL] [Abstract][Full Text] [Related]
7. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.
Dougan T; Levy JB; Salama A; George AJ; Pusey CD
Clin Exp Immunol; 2002 Jun; 128(3):555-61. PubMed ID: 12067312
[TBL] [Abstract][Full Text] [Related]
8. [The distribution and clinical significance of IgG subclasses of anti-glomerular basement membrane antibodies].
Yan Y; Cui Z; Zhao MH
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):501-4. PubMed ID: 15489931
[TBL] [Abstract][Full Text] [Related]
9. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge issues in Goodpasture's disease.
Chan AL; Louie S; Leslie KO; Juarez MM; Albertson TE
Clin Rev Allergy Immunol; 2011 Oct; 41(2):151-62. PubMed ID: 21207195
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease.
Kuang H; Shen CR; Jia XY; Tan M; Yang XF; Cui Z; Borza DB; Zhao MH
Kidney Int; 2023 Dec; 104(6):1124-1134. PubMed ID: 37598856
[TBL] [Abstract][Full Text] [Related]
12. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity.
Zhao J; Yan Y; Cui Z; Yang R; Zhao MH
Hum Immunol; 2009 Jun; 70(6):425-9. PubMed ID: 19364515
[TBL] [Abstract][Full Text] [Related]
13. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.
Ohlsson S; Herlitz H; Lundberg S; Selga D; Mölne J; Wieslander J; Segelmark M
Am J Kidney Dis; 2014 Feb; 63(2):289-93. PubMed ID: 24189476
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
15. Natural autoantibodies against glomerular basement membrane exist in normal human sera.
Cui Z; Wang HY; Zhao MH
Kidney Int; 2006 Mar; 69(5):894-9. PubMed ID: 16518348
[TBL] [Abstract][Full Text] [Related]
16. Laminin-521: a novel target for pathogenic autoantibodies in anti-glomerular basement membrane disease.
Robson KJ
Kidney Int; 2023 Dec; 104(6):1054-1056. PubMed ID: 37981425
[TBL] [Abstract][Full Text] [Related]
17. A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis.
Sporinova B; McRae SA; Muruve DA; Fritzler MJ; Nasr SH; Chin AC; Benediktsson H
BMC Nephrol; 2019 Jan; 20(1):29. PubMed ID: 30704432
[TBL] [Abstract][Full Text] [Related]
18. [GOODPASTURE'S SYNDROME--CASE REPORTS].
Kotur G; Kotur G; Horvatić I; Galešić D; Jubanović L; Galešić K
Lijec Vjesn; 2015; 137(5-6):171-6. PubMed ID: 26380476
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
20. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
